|
|
|
|
|
|
| Available: Yes* |
| This title does not qualify for any discount. |
|
Other formats:
|
| Edition: | 3rd |
| Publisher: | AMIRSYS Inc |
| ISBN: | 0-443-11280-0 (0443112800) |
| ISBN-13: | 978-0-443-11280-5 (9780443112805) |
| Format: | Atlas |
| Binding: | E E Book + ProQuest Ebook Central |
| Copyright: | 2024 |
| Publish Date: | 01/24 |
| Weight: | 0.00 Lbs. |
| Carton Quantity: | 4 |
| Subject Class: | PTH (Pathology) |
| Return Policy: | Non-Returnable. |
| |
|
| ProQuest Ebook Central�: |
Please sign in to preview this title
|
|
|
| |
| ISSN Series: | Diagnostic Pathology | | Discipline: | Pathology | | Subject Definition: | Molecular Diagnostic Techniques-Atlases | | NLM Class: | QZ 17 | | LC Class: | RB43.7 | | Abstract: | This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Providing a clear understanding of molecular pathology as it relates to the transformation and pathogenesis of cancer in an era of personalized medicine, it incorporates the most recent scientific and technical knowledge in the field to provide a comprehensive overview of all key issues relevant to today...s practice. Richly illustrated and easy to use, the third edition of Diagnostic Pathology: Molecular Oncology is a visually stunning, one-stop resource for every practicing pathologist, hematopathologist, molecular pathologist, oncologist, or pathologist in training as an ideal day-to-day reference or as a reliable learning resource. New to this edition: Molecular oncology is a rapidly evolving field with tremendous amounts of information that is new since the 2e published in March 2019. There is new molecular genetic data linked to either new targeted therapies or that serves as diagnostic or prognostic indicators. The 3e will include 8-10 new chapters and substantial updates and rewrites to existing contents to make sure ongoing edits and revisions to the upcoming WHO Classification of Hematopoietic Tumors are included in the 3e. The authors provide guidance on selecting the right test(s) at the right time for the right patient and comparisons of molecular testing methods (i.e., FSH testing vs. cytogenetics) are included. The market lacks a definitive source of all the recent changes, and DP3 Molecular Oncology will provide a comprehensive information source. |
|
|
* Subject to ProQuest Ebook Central� availability |
|
|
|
|
|
Follow Matthews Book Co. on:
Copyright © 2001-2025 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews